Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bioavailability of Pancreatic Enzymes in the Human Upper Intestine (Duodenum and Jejunum)

This study has been terminated.
(No longer required study by FDA for NDA approval.)
Sponsor:
Collaborator:
St. Louis University
Information provided by (Responsible Party):
Digestive Care, Inc.
ClinicalTrials.gov Identifier:
NCT00749099
First received: September 7, 2008
Last updated: February 20, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2010
  Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)